BioCentury | Nov 10, 2017
Financial News

AnchorDx raises $28M in series B

...the WuXi PharmaTech Inc. subsidiary of New WuXi Life Science Ltd. (Shanghai, China) and Guangzhou KingMed...
BioCentury | Nov 7, 2017
Financial News

AnchorDx raises $28M in series B round

...the WuXi PharmaTech Inc. subsidiary of New WuXi Life Science Ltd. (Shanghai, China) and Guangzhou KingMed...
...Capital invested in AnchorDx's series A round. The start-up was founded in 2015. Allison Johnson Arch Venture Partners KingMed...
BioCentury | Mar 12, 2012
Company News

KingMed, Qiagen sales and marketing update

...and KingMed will co-market Qiagen's Digene HPV test in China. Qiagen, which said partnering with KingMed...
...areas, already markets the HPV-based cervical cancer screening test in China. Terms were not disclosed. KingMed...
Items per page:
1 - 3 of 3
BioCentury | Nov 10, 2017
Financial News

AnchorDx raises $28M in series B

...the WuXi PharmaTech Inc. subsidiary of New WuXi Life Science Ltd. (Shanghai, China) and Guangzhou KingMed...
BioCentury | Nov 7, 2017
Financial News

AnchorDx raises $28M in series B round

...the WuXi PharmaTech Inc. subsidiary of New WuXi Life Science Ltd. (Shanghai, China) and Guangzhou KingMed...
...Capital invested in AnchorDx's series A round. The start-up was founded in 2015. Allison Johnson Arch Venture Partners KingMed...
BioCentury | Mar 12, 2012
Company News

KingMed, Qiagen sales and marketing update

...and KingMed will co-market Qiagen's Digene HPV test in China. Qiagen, which said partnering with KingMed...
...areas, already markets the HPV-based cervical cancer screening test in China. Terms were not disclosed. KingMed...
Items per page:
1 - 3 of 3